Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
31 studies found for:    "Hepatorenal syndrome"
Show Display Options
Rank Status Study
1 Completed Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1
Condition: Hepatorenal Syndrome
Intervention: Drug: terlipressin
2 Completed
Has Results
Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients
Condition: Hepatorenal Syndrome
Interventions: Drug: Ifetroban Injection;   Drug: Placebo
3 Completed Noradrenalin vs Terlipressin in Hepatorenal Syndrome
Condition: Hepatorenal Syndrome
Interventions: Drug: Terlipressin;   Drug: Noradrenalin
4 Terminated A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome
Condition: Hepatorenal Syndrome Type I and Type II
Intervention: Drug: LJPC-501
5 Terminated Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline
Condition: Hepatorenal Syndrome
Interventions: Drug: Pentoxyfylline;   Drug: Placebo;   Drug: AMO Therapy
6 Completed Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis
Condition: Hepatorenal Syndrome
Intervention: Drug: Terlipressin and albumin
7 Recruiting Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients
Condition: Hepatorenal Syndrome
8 Withdrawn To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome
Condition: Hepatorenal Syndrome
Interventions: Drug: nor adrenaline and terlipressin;   Drug: step up terlipressin therapy
9 Recruiting Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg
Condition: Hepatorenal Syndrome
Intervention: Drug: Norepinephrine (Levophed)
10 Completed A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1
Condition: Hepatorenal Syndrome Type 1
Intervention: Drug: Terlipressin
11 Active, not recruiting Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response
Conditions: Cirrhosis;   Hepatorenal Syndrome Type I
Intervention: Drug: Terlipressin and albumin
12 Recruiting The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure
Condition: Hepatorenal Syndrome
Intervention: Drug: Terlipressin
13 Suspended Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin
Conditions: Cirrhosis;   Hepatorenal Syndrome
Intervention: Drug: terlipressin
14 Recruiting A Study To Confirm Efficacy and Safety of Terlipressin in HRS Type 1
Condition: Hepatorenal Syndrome
Interventions: Drug: Terlipressin acetate;   Other: Placebo Comparator
15 Terminated Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
Conditions: Cirrhosis;   Hepatorenal Syndrome
Interventions: Drug: Terlipressin plus albumin;   Drug: Midodrine plus octreotide plus human albumin
16 Unknown  Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome
Conditions: Cirrhosis;   Type 1 Hepatorenal Syndrome
Interventions: Drug: terlipressin given by intravenous boluses and albumin;   Drug: terlipressin given by continuous intravenous infusion and albumin
17 Completed Plasma and Hemodynamic Markers During Hepatectomy
Condition: Hepatorenal Syndrome, Liver Regeneration
Intervention: Procedure: Liver resection
18 Terminated Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome
Conditions: Hepatorenal Syndrome;   Renal Failure;   Liver Diseases
Interventions: Procedure: Blood Draws and a hepatectomy specimen;   Procedure: Blood draw - pre operative standard of care
Condition: Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS
Interventions: Drug: Noradrenaline;   Drug: Terlipressin
20 Completed A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Condition: HRS
Interventions: Drug: Terlipressin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.